A charity campaign is usually judged on donations. This one is built to change what people think they are looking at – and the medium is the argument.
The campaign
Breakthrough T1D, formerly JDRF, marked World Diabetes Day on 14 November by announcing the continuation and global expansion of its “See T1D” campaign. The out-of-home marketing campaign can be seen throughout November, National Diabetes Awareness Month, and its marquee element was a Times Square digital billboard takeover on the day itself.
The takeover carried ads featuring two Breakthrough T1D celebrity advocates who live with type 1 diabetes: Robin Arzon, Peloton head instructor and host of Project Swagger, and J.J. Spaun, the 2025 U.S. Open and three-time PGA Tour champion. Alongside them, the screens ran community stories – the campaign’s central device is portraiture rather than statistics.
Following last year’s nationwide launch, the 2026 movement expands across global channels, Breakthrough T1D affiliate partners and media platforms. The stated aims are to increase global awareness of T1D, celebrate the resilience of people living with the condition, and highlight progress toward cures, clinical trials, early detection and new therapies.
“Expanding ‘See T1D’ allows Breakthrough T1D to shine an even brighter light on the everyday realities and extraordinary breakthroughs within our type 1 diabetes community,” said Pam Morrisroe, chief marketing officer at Breakthrough T1D. “World Diabetes Day is a powerful moment to unite people living with T1D and their loved ones, challenge misconceptions, and demonstrate how research and advocacy are actively transforming lives.”
Why the medium fits the message
Type 1 diabetes is an autoimmune condition that causes the pancreas to make very little insulin or none at all. It requires constant, lifelong management, and can be diagnosed at any age regardless of diet or family history. It affects nearly nine million people, and there is no cure.
The misconceptions the campaign is fighting are specific: that T1D is a childhood disease, that it is caused by lifestyle, that it is the same as type 2. Those are beliefs people absorb passively, not questions they search for. Out-of-home is the medium that reaches people who are not looking – which is why it is the right channel for a category-education problem and the wrong channel for a donation appeal.
A screen in Times Square cannot take a donation. It can, however, put a face on a condition in front of millions of people in a place where being seen is the entire point. The campaign’s own tagline makes the logic explicit: see the people behind the condition.
“Visibility matters. When we share our stories, someone else living with type 1 diabetes can see themselves in them – and know they’re not alone,” said Arzon. “T1D is part of my story, but it doesn’t get to define what I’m capable of.”
Spaun’s quote does similar work for a different audience: “Type 1 diabetes has challenged me in ways most people don’t see, but it’s also made me more resilient, disciplined, and determined. If my journey can inspire someone living with T1D to believe in themselves, then that means everything to me.”
The structure of the buy
The campaign’s two subthemes are unusually clear for a charity: “See the Everyday”, which centres lived experience and highlights the physical, emotional and financial burdens of managing T1D while pushing for broader access and affordability; and “See the Breakthroughs”, which demonstrates how research, advocacy, early detection screening and clinical trials are changing outcomes.
That split is a media plan as much as a message. “See the Everyday” belongs on mass-reach screens where it can shift public assumptions. “See the Breakthroughs” belongs in environments where the audience includes clinicians, payers and policymakers – trade press, conference media, airport and business districts.
OUTFRONT, which supplied the inventory, framed the partnership in exactly those terms. “IRL media has a unique power to connect with millions of people through visually compelling, personal stories,” said Nick Brien, chief executive of OUTFRONT. “We are proud to partner with Breakthrough T1D to bring the authentic, lived experiences of the type 1 diabetes community to prominent public spaces, driving critical awareness and inspiring action nationwide.”
There is a commercial subtext worth naming. Media owners compete to be associated with purpose campaigns because they demonstrate the medium’s civic value to advertisers who might otherwise treat out-of-home as pure performance inventory. A charity takeover in Times Square is good for OUTFRONT’s positioning as well as for the charity’s reach, and both parties know it.
What “takeover” is worth
One day of Times Square inventory buys a spike of attention and a wave of coverage – the campaign was reported by national outlets within hours. What it does not buy is retention. Awareness campaigns that rely on a single high-visibility moment tend to produce a measurable lift that decays within weeks, unless the message is repeated in the environments where the audience actually lives.
That is why the month-long out-of-home run matters more than the takeover, and why the global affiliate expansion is the part to watch. A condition that affects nearly nine million people is not under-recognised because nobody has heard of it; it is under-recognised because most people hold a wrong mental model of who gets it and why. Changing a mental model requires frequency, not spectacle.
The measurement question is the same one that hangs over every purpose campaign: what would success look like? Impressions are available. Shifts in misconception – the belief that T1D is caused by diet, for instance – would require survey work before and after, in the markets where the campaign actually ran. That data is rarely published, and its absence is why charity out-of-home is usually praised rather than evaluated.
Why it matters, in one line
Handing Times Square to people who live with type 1 diabetes is a bet that recognition beats information – and with nearly nine million people affected and no cure, the campaign’s real test is whether a month of frequency changes the misconception that T1D is a childhood, lifestyle-linked disease.
